301 related articles for article (PubMed ID: 29857863)
21. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
Barbieri S; Schroeder C; Froehlich JM; Pasch A; Thoeny HC
Contrast Media Mol Imaging; 2016 May; 11(3):245-50. PubMed ID: 26929131
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
[TBL] [Abstract][Full Text] [Related]
23. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
[TBL] [Abstract][Full Text] [Related]
24. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
25. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
26. Do Gadolinium-Based Contrast Agents Affect
Bauer K; Lathrum A; Raslan O; Kelly PV; Zhou Y; Hewing D; Botkin C; Turner JA; Osman M
J Nucl Med Technol; 2017 Mar; 45(1):30-33. PubMed ID: 27834725
[TBL] [Abstract][Full Text] [Related]
27. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
[TBL] [Abstract][Full Text] [Related]
28. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
[TBL] [Abstract][Full Text] [Related]
29. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
Ozturk K; Nascene D
AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
[No Abstract] [Full Text] [Related]
30. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
[TBL] [Abstract][Full Text] [Related]
31. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
Koiso T; Yamamoto M; Watanabe S; Barfod BE
Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
[TBL] [Abstract][Full Text] [Related]
32. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal Contrast-Enhanced Magnetic Resonance Imaging-Related Brain Signal Changes: Residual Gadolinium Deposition?
Öner AY; Barutcu B; Aykol Ş; Tali ET
Invest Radiol; 2017 Apr; 52(4):195-197. PubMed ID: 27755154
[TBL] [Abstract][Full Text] [Related]
34. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
[TBL] [Abstract][Full Text] [Related]
36. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
37. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
[TBL] [Abstract][Full Text] [Related]
38. Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years.
Kromrey ML; Liedtke KR; Ittermann T; Langner S; Kirsch M; Weitschies W; Kühn JP
Eur Radiol; 2017 Feb; 27(2):772-777. PubMed ID: 27221561
[TBL] [Abstract][Full Text] [Related]
39. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
Ozturk K; Nascene D
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
